The effect of high-flux hemodialysis on dialysis-associated amyloidosis

Renal Failure

Volumn 27, Issue 1, 2005, Pages 31-34

  Ayli, Meltem ^a,c   Ayli, Deniz ^a,c   Azak, Alper ^a,c   Yuksel C ^a   Atilgan, G ^a   Dede, F ^a   Akalin, T ^a   Abayli, E ^a   Camlibel M ^b  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Ya am Dialysis Center   (Turkey)

^c Ankara Numune Egitim ve Arastirma Hastanesi   (Turkey)

Author keywords

Amyloidosis; Beta 2 microglobulin; Hemodialysis; High flux

Indexed keywords

BETA 2 MICROGLOBULIN;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; CALCIUM METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; KIDNEY AMYLOIDOSIS; KIDNEY CLEARANCE; KIDNEY FAILURE; MALE; MOLECULAR WEIGHT; PHOSPHATE METABOLISM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; AMYLOIDOSIS; BETA-GLOBULINS; CALCIUM; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHOSPHORUS; RENAL DIALYSIS;

EID: 13144286439     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-42868     Document Type: Article

References (14)

1. U.S. Renal Data System, In USRDS 1997 Annual Data Report; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, April 1999.
2. Foley, R.N.; Parfrey, P.S.; Sarnak, M.J. Clinical epidemiology of cardiovascular disease in chronic renal failure. Am. J. Kidney Dis. 1998, 32 (Suppl. 3), 112-119.
3. Koch, K.M. Dialysis-related amyloidosis. Kidney Int. 1992, 41, 1416-1429.
4. Von Albertini, B.; Miller, J.H.; Gardener, P.W.; Shinaberger, J.H. Performance characteristics of the hemoflow F60 in high-flux hemofiltration. Contrib. Nephrol. 1985, 46, 69-70.
5. Van Ypserele, C.; Jadoul, M.; Malghem, J.; Maldague, B.; Jamart, J. Effect of dialysis membranes and patients ages on signs of dialysis related amyloidosis. Kidney Int. 1991, 39, 1012-1019.
6. Shimizu, S.; Yasui, C.; Yasukawa, K.; Nakamura, H.; Shimizu, H.; Tsuchiya, K. Subcutaneous nodules on the buttocks as a manifestation of dialysis-related amyloidosis: a clinicopathological entity? Br. J. Dermatol. 2003, 149 (2), 400-404.
7. Daugirdas, J.T.; Depner, T.A.; Gotch, F.A.; Greene, T.; Keshaviah, P.; Levin, N.W.; Schulman, G. Comparison of methods to predict equilibrated Kt/ V in the HEMO pilot study. Kidney Int. 1997, 52 (5), 1395-1405.
8. Locatelli, F.; Andrulli, S.; Pecchini, F. Effect of high-flux dialysis on the anemia of hemodialysis patients. Nephrol. Dial. Transplant. 2000, 15, 1399-1409.
9. Kim, S.T.; Yamamoto, C.; Taoka, M.; Takasugi, M. Programmed filtration, a new method for removing large molecules and regulating albumin leakage during hemodiafiltration treatment. Am. J. Kidney Dis. 2001, 38 (4 Suppl. 1), S220-S223.
10. Moe, S.M.; Drucke, T.B. Management of secondary hyperparathyroidism: the importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product. Am. J. Nephrol. 2003, 23 (6), 369-379.
11. Brancaccio, D.; Cozzolino, M.; Gorio, A.; Di Giulio, A.M.; Gallieni, M. Bone disease in uremic patients: advances in PTH suppression. J. Nephrol. 2002, 15 (Suppl. 6), S86-S93.
12. Koda, Y.; et al. Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int. 1997, 52, 1096-1101.
13. Küche, C.; et al. High-flux hemodialysis postpones clinical manifestations of dialysis related amyloidosis. Am. J. Nephrol. 1996, 16, 484-488.
14. Schiffl, H.; Fischer, R.; Lang, S.M.; Mangel, E. Clinical manifestations of AB-amyloidosis: effect of biocompatibility and flux. Nephrol. Dial. Transplant. 2000, 15, 840-845.